We thank the physicians and staff at Washington University School of Medicine, and Barnes-Jewish Hospital for collecting and curating COVID-19 plasma samples. The sample collection project was organized by Jane O’Halloran, Rachel Presti, and Phillip Mudd. Samples were processed at the Siteman Cancer Center Tissue Procurement Center, and access to samples was coordinated by Washington University’s Institute of Clinical and Translational Sciences. We are grateful to Checkable Medical for donations of AlfaAlfa and Sienna diagnostic test kits. We are also grateful to Jilian Sacks from the Foundation for Innovative New Diagnostics for her support and for useful discussions. The American Society of Tropical Medicine and Hygiene has waived the Open Access fee for this article due to the ongoing COVID-19 pandemic.
Tang YW , Schmitz JE , Persing DH , Stratton CW , 2020. The laboratory diagnosis of COVID-19 infection: current issues and challenges. J Clin Microbiol 58: e00512–e00520.
Li H , Pan J , Su Y , Wang B , Ge J , 2020. SARS-CoV-2 IgM/IgG antibody detection confirms the infection after three negative nucleic acid detection. J Cell Mol Med 24: 8262–8265.
Corman VM , Rabenau HF , Adams O , Oberle D , Funk MB , Keller-Stanislawski B , Timm J , Drosten C , Ciesek S , 2020. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission. Transfusion 60: 1119–1122.
Burbelo PD , Riedo FX , Morishima C , Rawlings S , Smith D , Das S , Strich JR , Chertow DS , Davey RT , Cohen JI , 2020. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J Infect Dis 222: 206–213.
- Search Google Scholar
- Export Citation
Burbelo PD Riedo FX Morishima C Rawlings S Smith D Das S Strich JR Chertow DS Davey RT Cohen JI 2020. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J Infect Dis 222: 206– 213.
Demey B , Daher N , Francois C , Lanoix JP , Duverlie G , Castelain S , Brochot E , 2020. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. J Infect 81: e6–e10.
Hoffman T , Nissen K , Krambrich J , Ronnberg B , Akaberi D , Esmaeilzadeh M , Salaneck E , Lindahl J , Lundkvist A , 2020. Evaluation of a COVID-19 IgM and IgG rapid test: an efficient tool for assessment of past exposure to SARS-CoV-2. Infect Ecol Epidemiol 10: 1754538.
- Search Google Scholar
- Export Citation
Hoffman T Nissen K Krambrich J Ronnberg B Akaberi D Esmaeilzadeh M Salaneck E Lindahl J Lundkvist A 2020. Evaluation of a COVID-19 IgM and IgG rapid test: an efficient tool for assessment of past exposure to SARS-CoV-2. Infect Ecol Epidemiol 10: 1754538.
Li Z et al.2020. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol 92: 1518–1524.
Montesinos I et al.2020. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol 128: 104413.
Okba NMA et al.2020. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis 26: 1478–1488.
Foundation for Innovative New Diagnostics , 2020. FIND Evaluation Update: SARS-COV-2 Immunoassays. Available at: https://www.finddx.org/covid-19/sarscov2-eval-immuno/. Accessed July 20, 2020.
United States Food and Drug Administration. Available at: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/eua-authorized-serology-test-performance. Accessed October 1, 2020.
Van Elslande J , Houben E , Depypere M , Brackenier A , Desmet S , Andre E , Van Ranst M , Lagrou K , Vermeersch P , 2020. Diagnostic performance of 7 rapid IgG/IgM antibody tests and the EUROIMMUN IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect 26: 1082–1087.
Whitman JD et al.2020. Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nat Biotechnol 38: 1174–1183.
Adams ER , et al.2020. Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel. Wellcome Open Res 5: 139.
Andersen BJ et al.2019. Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis. PLoS Negl Trop Dis 13: e0007697.
Kipp W , Kabwa P , Verbeck A , Fischer P , Eggert P , Buttner DW , 1995. Prevalence and risk factors of HIV-1 infection in three parishes in western Uganda. Trop Med Parasitol 46: 141–146.
Benjamini Y , Hochberg Y , 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57: 289–300.
Bastos ML et al.2020. Diagnostic accuracy of serological tests for COVID-19: systematic review and meta-analysis. BMJ 370: m2515.
Deeks JJ et al.2020. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev 6: CD013652.
World Health Organization , 2020. Target Product Profile for Priority Diagnostics to Support Response to the COVID-19 Pandemic, v.10. Geneva, Switzerland: WHO.
Pickering S et al.2020. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog 16: e1008817.
Herroelen PH , Martens GA , De Smet D , Swaerts K , Decavele AS , 2020. Humoral immune response to SARS-CoV-2. Am J Clin Pathol 154: 610–619.
U.S. Food and Drug Administration , 2020. COVID-19: In Vitro Diagnostics EUAs. Available at: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-serological. Accessed October 13, 2020.
Perkmann T et al.2020. Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity. Clin Chem 66: 1405–1413.